Earlier, Maharashtra Food & Drugs Administration (FDA) had written to the Department of Pharmaceuticals after finding large mark-ups in medicines and other consumables sold through hospital pharmacies in its survey, and sought monitoring of prices. The Maharashtra FDA found mark-ups of more than 28 times on intravenous infusion sets, around ten times for catheters, and similar mark-ups for various other medicines.
